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Kathryn B. Garber1,*MeCP2 Keeps Neurons from Getting Too Jumpy
Approximately 17% of the human genome is thought to be
composed of L1 elements, a small fraction of which main-
tain the capacity to move to another location. This move-
ment was thought to be restricted to germ cells early in
development, but it turns out that L1 activity can be
detected in neuronal precursor cells. One can even find
evidence of this activity in vivo in that quantitative PCR
indicates that there are more copies of L1 in the adult
human brain relative to other tissues from the same indi-
vidual. The increased L1 activity during brain development
has led to the suggestion that these jumping genes could
contribute to somaticmosaicismandmay influence expres-
sion of neuronal genes in healthy individuals. Could L1
elementsalso influencevariability inaneurodevelopmental
phenotype, namely Rett syndrome? Muotri et al. recently
found that the absence of MeCP2, the protein that is defec-
tive in Rett syndrome, is associated with increased L1
activity in neural stem cells, and this adds to our under-
standing of the regulation of L1 activity. They report that
Mecp2 knockout mice exhibit, in several areas of the brain,
increased neuronal L1 retrotransposition relative to that
of wild-type mice. These results appear to hold true in
patients with Rett syndrome, who also have increased L1
copy number in brain samples relative to age-matched
controls. Although it is plausible that these jumping L1s
may give rise to some variability in the Rett syndrome
phenotype, they cannot be the key to disease pathogenesis
because we know that we can reverse symptoms in mature
Mecp2 mutant mice if we turn the gene back on and this
would not be expected to reverse the L1 movements.
Muotri et al. (2010). Nature 468, 443–446. 10.1038/
nature0954.
Modulating Histone Aceylation to Alter FMR1
Transcription
Transcriptional silencing of FMR1 gives rise to fragile X
syndrome. This occurs when large expansions of the CGG
repeat tract in the 50 untranslated region of FMR1 are hyper-
methylated. On the other hand, excess transcription of this
gene occurs when there are smaller, premutation alleles of
this CGG repeat, and this ‘‘toxic’’mRNA is believed to cause
the fragile X tremor ataxia syndrome (FXTAS).Why are pre-
mutation alleles overexpressed? Todd et al. recently found
evidence that increased histone aceylation at the CGG
repeat is responsible, and these histone modifications can1Department of Human Genetics, Emory University School of Medicine, Atlan
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In a Drosophila neurodegeneration model of FXTAS,
overexpression of various histone deacetylases (HDACs)
suppresses the toxicity due to RNA containing repetitive
CGG sequences; knockdown of the same HDACs worsens
the phenotype. In cell lines from patients with premuta-
tion-sized alleles, drugs that block histone acetylation—
including one that is a natural compound derived from
cashews—decrease FMR1 mRNA expression to control
levels. Thus, chromatin remodeling is instigated by premu-
tation alleles, and this process appears to be central to pre-
mutation-associated disease. If you read on further in this
column, you’ll see that this work has implications for
a significant number of people; recent estimates suggest
that FXTAS could occur inmore than 1 in 5000 individuals.
Todd et al. (2010). PLOS Genetics. Published online
December 9, 2010. 10.1371/journal.pgen.1001240.
Eating Less to Eat More
Ullrich congenital muscular dystrophy (UCMD) and
Bethlem myopathy are muscular disorders on the same
continuum and are due to collagen type VI defects. Muscle
from affected individuals exhibits mitochondrial dysfunc-
tion and apoptosis, which leads to degeneration of myofib-
ers. Grumati et al. recently found evidence that this
downward spiral is at least partly due to defects in the stim-
ulation of autophagy, which shouldnormally be used to get
rid of dysfunctional mitochondria in order tomaintain cell
viability. Oneway to stimulate autophagy is through short-
term starvation, which did, in fact, stimulate autophagy
and decrease apoptosis in collagen VI-deficient mice. Obvi-
ously, this is not a sustainable therapeutic approach, so the
authors move to a low-protein diet to stimulate autophagy
and demonstrate recovery of dystrophic changes inmuscle
and improved muscle strength in the same mouse model.
Although it remains to be seen whether dietary manipula-
tion can alleviate muscle weakness in patients with
UCMD or Bethlem myopathy, this work hints that in the
context of collagen typeVI deficiency, eating less stimulates
muscle cells to increase their consumption of defective
organelles, which could alleviate muscle atrophy.
Grumati et al. (2010). Nature Medicine 16, 1313–1320.
10.1038/nm.2247.
Genome Architecture
Although the completion of a draft human genome
sequence was announced more than ten years ago,ta, GA 30322, USA
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technical limitations have hampered the delineation of
structural variation. Evan Eichler’s group has been tackling
this through the construction and capillary-based
sequencing of genome libraries in fosmid vectors. Discrep-
ancies in the length or orientation of fosmid end
sequences, compared to the human reference genome,
suggest copy-number variation or inversion. This group
recently announced the availability of a set of more than
13 million fosmid clones from 17 individuals, and they
characterize more than 2000 breakpoint junctions from
structural variants identified through this resource. The
three key mechanisms for generating this structural varia-
tion, as inferred from this breakpoint analysis, are micro-
homology-mediated processes, L1 retrotransposition, and
nonallelic homologous recombination. Evidence for
more complicated events at some junctions is also found,
including multiple rounds of gene conversion leading to
alternating sequences derived from flanking homologous
sequences. The availability of this clone resource should
facilitate additional analysis of these breakpoints and
lead to an even greater understanding of the structural
variation in the human genome.
Kidd et al. (2010). Cell 143, 837–847. 10.1016/
j.cell.2010.10.027.
Mutations in VCP Cause Familial ALS
The genes disrupted in amyotrophic lateral sclerosis (ALS)
largely remain a mystery. For adult-onset neurodegenera-4 The American Journal of Human Genetics 88, 3–5, January 7, 2011tive disorders such as this, traditional gene hunting in
affected families can be impeded by the lack of surviving
affected individuals. To circumvent this problem, Johnson
et al. used whole-exome sequencing in an attempt to find
the causative mutation in an Italian family with ALS. They
sequenced the exomes of two affected family members and
used Sanger sequencing in a third affected relative to
further limit the potentially relevant shared sequence vari-
ants. Their analysis led them to a missense change in VCP,
a gene that has already been found to be mutated in
a different disease phenotype: inclusion body myopathy
with early-onset Paget disease of the bone and fontotem-
poral dementia (IBMPFD). In fact, relatives of some of
the probands in this study were given diagnoses of Paget
disease and dementia. However, prior to this study, VCP
mutations were not known to cause ALS, and it was previ-
ously believed that an ALS diagnosis in a patient with
a VCP mutation was an erroneous misinterpretation of
the inclusion body myopathy phenotype. Instead, this
work indicates that mutations in this gene account for
approximately 2% of familial ALS and, in fact, that ALS
may be the only phenotype present in an individual
with a VCP mutation. It further suggests that the broader
IBMPFD phenotype should be assessed in pedigrees with
familial ALS.
Johnson et al. (2010). Neuron 68, 857–864. 10.1016/
j.neuron.2010.11.036; Shaw (2010) Neuron 68, 812–814.
10.1016/j.neuron.2010.11.040.This Month in Our Sister JournalsTo Screen or Not to Screen: That Is the Question
Recent technological advances have made fragile X carrier
screening possible through the detection of females
heterozygous for premutation-sized alleles in FMR1.
Hantash et al. used one of the recently developed method-
ologies, triplet-primed PCR, to screen more than 13,000
anonymized samples for fragile X premutations and use
their results to argue for further consideration of popula-
tion-based carrier screening for fragile X syndrome. The
samples, which were gathered in the United States, were
originally referred for carrier screening for either cystic
fibrosis or genetic diseases that are more prevalent in the
Ashkenazi Jewish population. Together with United States
Census Bureau data, the authors use the results of their
screen to extrapolate an overall premutation-carrier
frequency of 1:178, a frequency higher than previous esti-
mates. If one were to argue simply on the basis of estimated
carrier frequencies, this number would support popula-
tion-based screening for fragile X premutation carriers
because it is higher than carrier frequencies of other
genetic disorders for which screening is already recom-
mended, including cystic fibrosis. The authors also usetheir data to estimate fragile X premutation-associated
diseases in the United States, yielding frequencies of
1:4848 for fragile X-associated tremor and ataxia syndrome
and 1:3560 for fragile X-associated primary ovarian insuffi-
ciency.
Hantash et al. (2010). Genetics in Medicine. Published on-
line November 24, 2010. 10.1097/GIM.0b013e3181fa9fad.
Location, Location, Location
Is the evolution of a genomic segment due to its sequence
or its context? DeBaryshe and Pardue examined this ques-
tion recently in their comparisons of the same retrotrans-
poson in two different contexts in the Drosophila genome.
Three retrotransposons maintain the length of Drosophila
telomeres, and one of these, HeT-A, is also found in the Y
chromosome centromere ofDrosophila and has beenmain-
tained there for over 13 million years. This gave them the
opportunity to compare HeT-A sequences that have been
maintained in a telomeric context with those in a centro-
meric context. Their analysis suggests that HeT-A gains
and loses sequences in different ways in the two different
contexts. Whereas the telomeric elements are often found
in their complete form and seem to degrade via gradual
erosion and irregular deletions from the terminal end,
the centromeric elements have each lost at least 40% of
their sequences via internal deletions. On the other
hand, the telomere arrays grow via new transposition
events, unlike the centromeric arrays, which grow byThamplification of internal sequences. Thus, the genome
appears to be driving the evolution of these elements on
the basis of location and probably on the basis of the func-
tion of the telomeric and centromeric regions.
DeBaryshe and Pardue (2010). Genetics. Published online
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